Therapy developed by IIT-Bombay spin-off company ImmunoACT approved for relapsed-refractory B-cell lymphoma, leukemia, to be available in around 20 govt & pvt hospitals across major cities.
Panel report notes that oral phenylephrine is no better than placebo for relieving nasal congestion. In India, phenylephrine is widely used in cough and cold medicines.
Project follows outcry over NMC rule, now on hold, asking medical practitioners to prescribe generics or face penalty. Dr Cyriac Abby Philips or ‘@TheLiverDoc’ part of project.
Pholcodine is used to treat dry cough. WHO had flagged risk of anaphylactic reactions in those who took remedies containing Pholcodine at least 12 months prior to surgery.
Low-cost tissue-engineering scaffold Cholederm — developed by Thiruvananthapuram-based Sree Chitra Tirunal Institute for Medical Sciences & Technology — approved by DCGI.
Pune-based SII has got the go-ahead from the Drugs Controller General of India to market the vaccine. Cervical cancer is one of the leading causes of female cancer mortality worldwide.
A press release from Corbevax maker said it could be administered as a booster after six months of administration of primary vaccination for restricted use in emergency situation.
The trial will be conducted across 10 sites in India. Zydus Cadila's ZyCoV-D is so far the only vaccine to get Emergency Use Authorisation in the 12-18 years age group in India.
DCGI modifies earlier order on emergency approval of well-established vaccines, waives several requirements, but retains assessment of first 100 beneficiaries before proper roll out.
Economists say there are weaknesses in India’s GDP data. But statisticians claim the accusations are based on flawed understanding, saying while GDP has problems, the economists are looking in the wrong places.
Coaching centres for Army aspirants in Jhunjhunu are shutting down due to plummeting admissions in the face of a lack of job guarantees under Agnipath Scheme.
COMMENTS